Skip to main content
. 2021 Sep 20;135(3):268–275. doi: 10.1097/CM9.0000000000001683

Figure 1.

Figure 1

Flowchart of the study selection on chromosomal microarray analysis vs. karyotyping for fetal ventriculomegaly.